The analyst suggests avoiding Infosys at its current price, as it is still considered overvalued despite a recent correction. While the company has strong long-term growth prospects and was a COVID-19 beneficiary, its growth is normalizing, and current multiples are above its historical average. A buy limit order at around 1260 Indian Rupees is recommended to achieve a more attractive long-term return.
“Für mich wäre das jetzt momentan kein guter Einstiegskurs. Ich würde eher hingehen und um die marktübliche langfristige Rendite abpassen durch einen Kursrückgang.”